| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/07/2001 | WO2001039799A2 Passive desensitization |
| 06/07/2001 | WO2001039798A1 Method of diagnosing, monitoring, staging, imaging and treating prostate cancer |
| 06/07/2001 | WO2001039795A2 Attenuation of fibroblast proliferation |
| 06/07/2001 | WO2001039794A1 Insulin-containing medicament for peroral application and method for the production thereof |
| 06/07/2001 | WO2001039793A2 Pharmaceutical compositions containing sema7a polypeptides |
| 06/07/2001 | WO2001039792A2 The use of caspase 9 inhibitors to treat ocular neural pathology |
| 06/07/2001 | WO2001039791A2 Tyrosine- and tryptophan-containing peptides as antioxidants |
| 06/07/2001 | WO2001039790A1 Methods of treating inflammation and compositions therefor |
| 06/07/2001 | WO2001039788A2 Methods for targeting cells that express fibroblast growth receptor-3 or-2 |
| 06/07/2001 | WO2001039786A2 New uses of suppressive macrophage activation factors |
| 06/07/2001 | WO2001039784A1 Pancreatic stem cells and their use in transplantation |
| 06/07/2001 | WO2001039781A1 Pharmaceutical combinations |
| 06/07/2001 | WO2001039780A1 Activation of novel estrogen receptor supports neuronal viability and function |
| 06/07/2001 | WO2001039758A2 Method for the treatment and/or prophylaxis of diseases caused by il-12 using thalidomide and anti-inflammatory cytokine |
| 06/07/2001 | WO2001039722A2 B7-h1, a novel immunoregulatory molecule |
| 06/07/2001 | WO2001039600A1 Use of hsp27 as an anti-inflammatory agent |
| 06/07/2001 | WO2001039573A2 Novel use of lung surfactant for treating legionnaire's disease |
| 06/07/2001 | WO2001032865A8 Human gpr27-like g-protein coupled receptor polypeptide and polynucleotide sequences |
| 06/07/2001 | WO2001020337A8 Genetic testing for periodontitis based on cathepsin c |
| 06/07/2001 | WO2001016158A3 Bridging integrator-2 (bin2) nucleic acid molecules and proteins and uses therefor |
| 06/07/2001 | WO2001013946A3 Method for isolating and purifying grass pollen allergens |
| 06/07/2001 | WO2001012213A3 Ttp-related zinc finger domains and methods of use |
| 06/07/2001 | WO2001011064A3 Polynucleotides regulating the activation of the expression of a gene in the heart and its uses in gene therapy |
| 06/07/2001 | WO2001010902A3 Nucleoc acids and secreted polypeptides encoded thereby |
| 06/07/2001 | WO2001010894A3 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| 06/07/2001 | WO2001010384A3 Method for identifying compounds for treatment of insulin resistance |
| 06/07/2001 | WO2001007612A3 Receptors and associated proteins |
| 06/07/2001 | WO2001001775A8 Preserving a hemoglobin blood substitute with a transparent overwrap |
| 06/07/2001 | WO2000078960A3 Compositions and methods for the therapy and diagnosis of breast cancer |
| 06/07/2001 | WO2000074703B1 Therapeutic agent comprising a botulinum neurotoxin |
| 06/07/2001 | WO2000032752A9 Psca: prostate stem cell antigen and uses thereof |
| 06/07/2001 | WO1999063940A3 INHIBITORS OF H+K+-ATPase |
| 06/07/2001 | WO1999063071A3 Method for triggering apoptosis in cells |
| 06/07/2001 | WO1999052548A9 Conjugate vaccines for the prevention of dental caries |
| 06/07/2001 | WO1999002187A3 Decreased fat absorption with an anti-lipase antibody |
| 06/07/2001 | US20010003119 Edible, wholly or partially nondigestible low calorie fatty acid polyesters having non-Newtonian pseudoplastic rheology at body temperature; substitute for triglyceride fats in low calorie fat-containing foods; for reducing serum cholesterol |
| 06/07/2001 | US20010003001 Compounds and compositions for delivering active agents |
| 06/07/2001 | DE19957916A1 Neue Proteinkonjugate und Verfahren zu deren Herstellung New protein conjugates and methods for their preparation |
| 06/07/2001 | DE19957898A1 Treatment of legionnaire's disease using pulmonary surfactant preparation, preventing acute lung injury or adult respiratory distress syndrome without risk of development of resistance |
| 06/07/2001 | DE19957043A1 Neue Defensine New defensins |
| 06/07/2001 | DE19955576A1 Transferverbindungen, ihre Herstellung und ihre Verwendung Transfer compounds, their preparation and their use |
| 06/07/2001 | CA2709291A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/07/2001 | CA2406316A1 Method of diagnosing, monitoring, staging, imaging and treating prostate cancer |
| 06/07/2001 | CA2394996A1 Transcription factors containing two potential dna binding motifs |
| 06/07/2001 | CA2394016A1 Novel endoplasmic localization proteins,therapeutic agents for glycoprotein aberration disorders containing same,dna encoding the proteins,and therapeutic agents in gene therapy for glycoprotein aberration disorders |
| 06/07/2001 | CA2393369A1 Human cytokine receptor |
| 06/07/2001 | CA2393186A1 Attenuation of fibroblast proliferation |
| 06/07/2001 | CA2392963A1 Methods for identifying compounds for motion sickness, vertigo and other disorders related to balance and the perception of gravity |
| 06/07/2001 | CA2392958A1 Methods and compositions for regulating lymphocyte activity |
| 06/07/2001 | CA2392948A1 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof |
| 06/07/2001 | CA2392941A1 Drug inducible system and use thereof |
| 06/07/2001 | CA2392906A1 Pseudomonas aeruginosa antigens |
| 06/07/2001 | CA2392895A1 Streptococcus pneumoniae antigens |
| 06/07/2001 | CA2392853A1 Hbv sequences |
| 06/07/2001 | CA2392795A1 Insulin-containing medicament for peroral application and method for the production thereof |
| 06/07/2001 | CA2392717A1 Cytokine receptor-like polynucleotides, polypeptides, and antibodies |
| 06/07/2001 | CA2392713A1 Novel antidiabetic agents |
| 06/07/2001 | CA2392693A1 Four disulfide core domain-containing (fdcd) polynucleotides, polypeptides, and antibodies |
| 06/07/2001 | CA2392615A1 Pancreatic stem cells and their use in transplantation |
| 06/07/2001 | CA2392510A1 Compositions and methods for therapy and diagnosis of breast cancer |
| 06/07/2001 | CA2392477A1 B7-h1, a novel immunoregulatory molecule |
| 06/07/2001 | CA2392110A1 Proteins and nucleic acids encoding the same |
| 06/07/2001 | CA2391455A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/07/2001 | CA2391402A1 Masp-3, a complement-fixing enzyme, and uses for it |
| 06/07/2001 | CA2390839A1 Transforming growth factor alpha hiii |
| 06/07/2001 | CA2390786A1 Compositions and methods for the treatment of immune related diseases |
| 06/07/2001 | CA2390415A1 New uses of suppressive macrophage activation factors |
| 06/07/2001 | CA2390349A1 Alpha-ketoamide inhibitors of hepatitis c virus ns3 protease |
| 06/07/2001 | CA2390088A1 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 06/07/2001 | CA2389262A1 Modified il-12 subunits and nucleic acids encoding them |
| 06/06/2001 | EP1104888A2 Isolation and characterization of the growth hormone releasing hormone receptor |
| 06/06/2001 | EP1104809A1 Process for producing alpha-interferon |
| 06/06/2001 | EP1104807A2 Apparatus for the production of TGF-beta |
| 06/06/2001 | EP1104771A1 NOVEL POLYPEPTIDE, cDNA ENCODING THE SAME AND UTILIZATION THEREOF |
| 06/06/2001 | EP1104770A2 Compositions and methods for detecting and treating acquired immunodeficiency syndrome |
| 06/06/2001 | EP1104677A2 Proteinconjugates and their preparation |
| 06/06/2001 | EP1104675A1 Agent for regulating iodine exchange or for preventing iodine-deficit conditions |
| 06/06/2001 | EP1104483A1 Molecular cloning of a 7tm receptor (gpr31a) |
| 06/06/2001 | EP1104482A2 Cell type specific gene transfer using retroviral vectors containing antibody-envelope fusion proteins and wild-type envelope fusion proteins |
| 06/06/2001 | EP1104475A1 C-myc is activated by beta-catenin and tcf-4 |
| 06/06/2001 | EP1104473A2 Proteases and associated proteins |
| 06/06/2001 | EP1104466A1 Leptin-related peptides |
| 06/06/2001 | EP1104465A1 14400 receptor, a g-protein coupled receptor |
| 06/06/2001 | EP1104464A2 Nucleic acids encoding a functional human purinoreceptor p2x2 and methods of producing and use thereof |
| 06/06/2001 | EP1104463A1 Role of human kis (hkis) as an inhibitory kinase of the cyclin-dependent kinase inhibitor p27. compositions, methods and uses thereof to control cell proliferation |
| 06/06/2001 | EP1104461A1 Grip, human adapter protein related to the grb2 family member |
| 06/06/2001 | EP1104460A1 Modulation of apoptosis with bid |
| 06/06/2001 | EP1104456A1 Engineered antigen-presenting cells expressing an array of antigens and uses thereof |
| 06/06/2001 | EP1104442A1 Papillomavirus cellular receptor |
| 06/06/2001 | EP1104441A1 Hiv suppressor factor derived from scrub typhus |
| 06/06/2001 | EP1104440A1 A g-protein coupled 7tm receptor (axor-1) |
| 06/06/2001 | EP1104438A2 Novel anti-diabetic peptides |
| 06/06/2001 | EP1104437A2 Antimicrobial peptides isolated from the skin of american frogs |
| 06/06/2001 | EP1104323A1 Apparatus and method of preparation of stable, long term thrombin from plasma and thrombin formed thereby |
| 06/06/2001 | EP1104310A1 Expression and characterization of hiv-1 envelope protein associated with a broadly reactive neutralizing antibody response |
| 06/06/2001 | EP1104309A2 Protected one-vial formulation for nucleic acid molecules, methods of making the same by in-line mixing, and related products and methods |
| 06/06/2001 | EP1104307A2 Pharmaceutical composition having inhibitory effect on overproduction and accumulation of extracellular matrix |
| 06/06/2001 | EP1104305A2 Cancer treatment |
| 06/06/2001 | EP1104304A1 Multivalent avb3 and metastasis-associated receptor ligands |
| 06/06/2001 | EP1104296A1 Bioimplant formulation |